Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

erythromycin lactobionate

Known as: erythromycin lactobionate [Chemical/Ingredient] 
The lactobionate salt form of erythromycin, a broad-spectrum, topical macrolide antibiotic with antibacterial activity. Erythromycin lactobionate… 
National Institutes of Health

Related topics

Related topics

33 relations
Acne VulgarisAstemizoleBacterial InfectionsCampylobacter infection
Expand

Broader (2)

Anti-Bacterial AgentsGastrointestinal Agents

Narrower (1)

Erythrocin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
Study on enantiomeric separation of basic drugs by NACE in methanol‐based medium using erythromycin lactobionate as a chiral selector
A wide variety of chiral selectors have been employed in CZE, and among them macrocyclic antibiotics including glycopeptides… 
Highly Cited
2001
Highly Cited
2001
Low-Dose Erythromycin Reduces Delayed Gastric Emptying and Improves Gastric Motility After Billroth I Pylorus-Preserving Pancreaticoduodenectomy
ObjectiveTo test the hypothesis that early and low doses of erythromycin reduce the incidence of early delayed gastric emptying… 
Highly Cited
1998
Highly Cited
1998
Cardiac actions of erythromycin: influence of female sex.
CONTEXT Erythromycin is a widely used antibiotic that infrequently causes QT-prolongation and torsades de pointes cardiac… 
Highly Cited
1996
Highly Cited
1996
Erythromycin stimulates gastric emptying after esophagectomy with gastric replacement: a randomized clinical trial.
UNLABELLED Delayed gastric emptying after esophagogastrectomy can pose a significant early postoperative problem. Because… 
Highly Cited
1995
Highly Cited
1995
QT Interval Prolongation and Torsades de Pointes Due to Erythromycin Lactobionate
Study Objectives. To discern the frequency of torsades de pointes and QT prolongation in patients receiving intravenous… 
Highly Cited
1993
Highly Cited
1993
Erythromycin accelerates gastric emptying after pancreaticoduodenectomy. A prospective, randomized, placebo-controlled trial.
OBJECTIVE This study tested the hypothesis that erythromycin, a motilin agonist, reduces the incidence of early DGE after… 
Highly Cited
1993
Highly Cited
1993
The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin.
The objective of this study was to investigate the effects of intravenous erythromycin and chronic oral dosing of erythromycin on… 
Highly Cited
1993
Highly Cited
1993
Electrophysiological Mechanisms in a Canine Model of Erythromycin‐Associated Long QT Syndrome
BackgroundErythromycin is known to prolong ventricular repolarization and has been associated with the occurrence of torsades de… 
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Highly Cited
1984
Highly Cited
1984
Erythromycin mimics exogenous motilin in gastrointestinal contractile activity in the dog.
The gastrointestinal motor stimulating activity of erythromycin (EM) was studied in conscious dogs. It was found that a 20-min… 
1973
1973
Transient perceptive deafness due to erythromycin lactobionate.
To the Editor.— Erythromycin may cause adverse reactions of two types: (1) allergic such as fever, eosinophilia, skin eruptions… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE